Four Technical Clusters Defining the Field
Biocatalytic carbon capture organises around four distinct technical sub-domains, each at a different stage of maturity and each targeting a different point in the CO₂ value chain. Understanding these clusters is the starting point for any IP or R&D strategy in this space. The four sub-domains—enzyme-facilitated membrane and solvent-based capture, engineered microbial CO₂ fixation, hybrid abiotic–biological systems, and new-to-nature enzyme engineering—span from near-commercial deployment to early-stage research, and they are not mutually exclusive: several of the most promising recent results combine elements of two or more clusters.
Biocatalytic carbon capture deploys biological catalysts—enzymes, whole-cell microorganisms, and engineered metabolic pathways—to capture, fix, or convert CO₂ more efficiently than purely chemical or physical methods. It sits at the intersection of synthetic biology, green chemistry, and climate engineering, and encompasses approaches from carbonic anhydrase-enhanced scrubbing to electrically driven microbial biosynthesis.
Cluster 1: Enzyme-Facilitated Membrane and Solvent-Based Capture
The most engineering-mature cluster uses carbonic anhydrase (CA) enzymes immobilized on membranes or delivered via structured packings to accelerate CO₂ hydration in potassium carbonate or other non-volatile alkaline salt solvents. Carbozyme and the Energy & Environmental Research Center demonstrated 85% CO₂ removal from a 15.4% CO₂ feed stream using a 0.5 m² CA permeator as early as 2009, establishing a baseline improvement over monoethanolamine (MEA) in both cost and energy. Akermin Inc.’s 2014 pilot extended this to a multi-year industrial demonstration on coal combustion flue gas. Griffith University’s 2019 proof-of-concept added a downstream conversion step, coupling CA for CO₂ capture with formate dehydrogenase (FDH) and electrochemical cofactor regeneration to produce formic acid at 40% conversion from captured CO₂.
Cluster 2: Engineered Microbial CO₂ Fixation
The most diverse cluster by organism type deploys metabolically engineered microorganisms—cyanobacteria, acetogens, E. coli, and autotrophs such as Cupriavidus necator—as whole-cell biocatalysts to fix CO₂ directly into target metabolites. Goethe University Frankfurt demonstrated in 2021 that recombinant expression of hydrogen-dependent CO₂ reductase (HDCR) from acetogenic bacteria in E. coli enables whole-cell H₂-driven CO₂ reduction to formate without exogenous cofactors. The University of Nottingham engineered marine cyanobacterium Synechococcus sp. PCC 7002 with riboswitch-controlled TCA flux reduction and enhanced citrate synthase to photosynthetically convert CO₂ to citric acid—a commercially important platform chemical.
Cluster 3: Hybrid Abiotic–Biological Systems
The most actively emerging technical area integrates electrochemical or photocatalytic CO₂ reduction with biological bioconversion to overcome the kinetic and thermodynamic limitations of either approach alone. Washington University in St. Louis (2022) systematically designed the electrocatalysis–biology interface using C2 intermediates (ethanol, acetate) to achieve 6× and 8× improvement in microbial biomass productivity versus C1 and H₂-driven routes for CO₂-to-bioplastics conversion. Northumbria University (2022) demonstrated interfacing photocatalysts with microbes to produce solar fuels and chemicals directly from CO₂ and sunlight, as documented by Nature-indexed research in the field of photobiocatalysis.
Cluster 4: New-to-Nature Enzyme Engineering
This cluster focuses on rational and high-throughput design of carboxylases and ligases that either do not exist in nature or have been dramatically improved. CNRS/Centre de Recherche Paul Pascal (2021) developed glycolyl-CoA carboxylase (GCC) by combining rational design with high-throughput microfluidics-assisted directed evolution, achieving a three-orders-of-magnitude improvement in catalytic efficiency verified by a 1.96 Å cryo-EM structure. The National Technology Innovation Center of Synthetic Biology in Tianjin (2021) catalogued newly mined and designed carboxylases and C–C ligases for CO₂, formaldehyde, CO, and formate transformation.
From Lab Curiosity to Pilot Plant: The Innovation Timeline
The publication timeline across retrieved records spans 2009–2024 and reveals three discernible phases of development, with innovation intensity increasing sharply in the most recent period. The earliest signal is the Carbozyme/EERC CA-membrane permeator work from 2009; the most recent cluster of results, from 2021–2023, represents the highest density of novel technical approaches in the dataset—indicating that the field is accelerating rather than plateauing.
Early Foundations (2009–2015): The Carbozyme/EERC CA-membrane permeator (2009) and Akermin’s 3,460-hour pilot on coal flue gas (2014) established the technical feasibility of enzyme-enhanced capture at industrial scale. The Australian National University’s 2015 review established the conceptual framework for enzyme-driven CO₂ utilization, identifying solar energy, electricity, and chemical oxidation as viable sources of reducing equivalents for enzymatic CO₂ fixation.
Mid-Stage Development (2016–2020): The University of Nottingham’s Synthetic Biology Research Centre introduced Cupriavidus necator as an aerobic chassis for C1 waste gas conversion (2016). Griffith University demonstrated a closed-loop formate cycling system (2019), and Tianjin University established the conceptual architecture for hybrid abiotic–biological CO₂ conversion (2020).
Recent & Emerging Filings (2021–2024): The most recent results cluster heavily in 2021–2023, with multiple institutions simultaneously advancing engineered photosynthetic biocomposites, electro-microbial CO₂-to-bioplastics systems, cyanobacterial chemical production, new-to-nature carboxylase design, and bio-based sorbents. The Jimei University 2022 review explicitly frames electrically driven microbial and enzyme engineering as the forward frontier of the field.
“3D cyanobacterial biocomposites on loofah sponge achieved CO₂ uptake rates of 1.57 g CO₂ g⁻¹ biomass d⁻¹—a 14–20× improvement over suspension cultures—projecting to 570 tCO₂ t⁻¹ biomass yr⁻¹ at scale.”
Explore the full patent and literature landscape for biocatalytic carbon capture in PatSnap Eureka.
Search Biocatalytic CO₂ Patents in PatSnap Eureka →Performance Benchmarks Across Biocatalytic Approaches
The quantitative performance data available across the dataset spans capture efficiency, operational duration, productivity improvements, and catalytic efficiency gains—providing a basis for comparing the four technical clusters against each other and against conventional MEA scrubbing. These benchmarks are the clearest signal of where the technology stands today and where the highest-leverage opportunities for further improvement lie.
Akermin Inc.’s carbonic anhydrase biocatalyst delivery system achieved 80% average CO₂ capture on coal combustion flue gas over a 3,460-hour pilot, with a 6–7× enhancement in volumetric mass transfer coefficient at 40°C compared to unenhanced potassium carbonate solvent.
Newcastle University’s 3D cyanobacterial biocomposites on loofah sponge achieved CO₂ uptake rates of 1.57 g CO₂ per gram of biomass per day—a 14–20× improvement over suspension cultures—projecting to 570 tCO₂ per tonne of biomass per year at scale, according to the 2022 study on engineered living photosynthetic biocomposites.
The Griffith University formate cycling system (2019) achieved 40% conversion of captured CO₂ to formic acid using carbonic anhydrase combined with formate dehydrogenase and electrochemical cofactor regeneration. The CNRS/CRPP glycolyl-CoA carboxylase work (2021) stands apart from the other benchmarks in kind rather than degree: a three-orders-of-magnitude improvement in catalytic efficiency represents a step-change in what is achievable through directed evolution combined with high-throughput microfluidic screening, as increasingly documented in synthetic biology literature tracked by WIPO‘s annual technology trends reports.
Multiple results in this dataset document systems where CO₂ capture and valorization occur in the same reactor—formate cycling, bioplastics production, and citric acid synthesis. Techno-economic advantage accrues to architectures that eliminate the separate capture, compression, and transport steps inherent to conventional carbon capture and storage (CCS). Product-integrated biocatalytic systems should be prioritised in portfolio construction.
Geographic and Institutional Landscape
Biocatalytic carbon capture innovation in this dataset is distributed across many institutions rather than concentrated in a few dominant corporate assignees—a pattern that distinguishes it from more mature clean technology fields and creates both opportunity and complexity for IP strategy. Three geographic clusters account for the majority of identifiable institutional activity: the United Kingdom, China, and the United States.
In the biocatalytic carbon capture patent and literature dataset spanning 2009–2024, the only commercial assignee with multi-year, scaled demonstration data is Akermin Inc. (US), which has since been acquired. National laboratories and synthetic biology centres—including Oak Ridge National Laboratory and the National Technology Innovation Center of Synthetic Biology in Tianjin—are emerging as the primary institutional anchors for next-generation approaches.
United Kingdom: The University of Nottingham appears across multiple results spanning 2016–2022, covering microbial chassis development, C1 chemistry, and cyanobacterial citric acid production. Newcastle University (2022) contributes the photosynthetic biocomposite work. The UK’s academic biocatalytic research base is the most consistently represented in the dataset.
China: The National Technology Innovation Center of Synthetic Biology and the Frontier Science Center for Synthetic Biology (both Tianjin), together with the Chinese Academy of Sciences and Jimei University (Xiamen), collectively represent the most active cluster for biocatalytic C–C bond formation and electrically driven microbial systems. The concentration of Tianjin-based results signals a coordinated national research program in synthetic biology-enabled carbon utilization—a pattern consistent with the innovation trajectories tracked by OECD in its bioeconomy policy assessments.
United States: Akermin Inc. (2014) remains the most commercially advanced biocatalyst delivery system in the dataset. Carbozyme Inc. and the Energy & Environmental Research Center (2009) hold the foundational enzyme-membrane patent position. Oak Ridge National Laboratory (2021) and Washington University in St. Louis (2022) contribute direct air capture and electro-microbial conversion work, respectively.
Australia, Germany, and France: Griffith University (2019) and Australian National University (2015) anchor the Australian presence, focused on bio-catalytic formate cycling and CO₂-to-feedstock enzymatic pathways. Goethe University Frankfurt (Germany, 2021) and CNRS/CRPP (France, 2021) are notable European contributors, with the CNRS work on new-to-nature carboxylase design representing the highest-impact single result in the dataset by catalytic efficiency improvement. Additional regional contributions come from Qatar University (2023), Yuan Ze University in Taiwan (2021), Universidad de Concepcion in Chile (2023), Covenant University in Nigeria (2021), and Northumbria University in the UK (2022), reflecting a genuinely global distribution of innovation activity consistent with the multilateral climate commitments tracked by the UNFCCC.
Map the full assignee and geographic landscape for biocatalytic CO₂ technology with PatSnap Eureka’s AI-powered patent analytics.
Analyse the Patent Landscape in PatSnap Eureka →Five Emerging Directions Shaping the Next Wave
Based on results published in 2021–2024, five forward-pointing innovation signals are identifiable within this dataset. Each represents a distinct technical trajectory with its own IP implications and deployment timeline.
1. Electro-Microbial CO₂ Conversion to Bioplastics and Polymers
Washington University in St. Louis (2022) demonstrated a systematic multi-tier engineering approach using C2 intermediates—ethanol and acetate—to bridge electrochemistry and microbial biosynthesis, achieving 6× and 8× improvement in microbial biomass productivity versus C1 and H₂-driven routes. This direction resolves long-standing mass transfer and metabolic kinetics bottlenecks that have limited earlier electro-microbial systems. IP claims in this space are early-stage and not yet consolidated by dominant assignees in this dataset.
2. Living Photosynthetic Biocomposites for Built-Environment Carbon Capture
Newcastle University’s 2022 demonstration projects CO₂ uptake scaling to 570 tCO₂ t⁻¹ biomass yr⁻¹ with land efficiency orders of magnitude better than bioenergy with carbon capture and storage (BECCS) forestry. The 3D loofah sponge scaffold architecture represents a qualitatively new deployment paradigm—structural biological systems for ambient CO₂ removal at building or landscape scale.
3. De Novo Carboxylase Design via Directed Evolution and High-Throughput Screening
The CNRS/CRPP 2021 glycolyl-CoA carboxylase work demonstrates three-orders-of-magnitude improvement in catalytic efficiency through microfluidics-assisted directed evolution—a methodology that will likely be applied broadly to other CO₂-fixing enzyme targets. The 1.96 Å cryo-EM structural verification sets a new benchmark for enzyme engineering validation in this field.
4. Cyanobacterial Platform Expansion for Direct CO₂-to-Chemical Photoproduction
The University of Nottingham’s 2022 cyanobacterium-to-citric-acid work uses riboswitch-controlled metabolic flux redirection—a synthetic biology precision tool that signals the maturation of cyanobacteria as industrial CO₂-fixing chassis. Riboswitch control of TCA cycle flux, combined with enhanced citrate synthase expression, enables photosynthetic CO₂ fixation to be directed toward specific platform chemical outputs.
5. Bio-Based Sorbents from Waste Streams
The Universidad de Concepcion 2023 review identifies food waste, agricultural, and municipal precursors for physically and chemically activated bio-sorbents, intersecting circular economy principles with carbon capture materials science. This direction is distinct from the enzymatic and microbial clusters—it applies biological feedstocks to produce improved sorbent materials rather than deploying living biological catalysts—and represents an emerging convergence point between waste valorization and CCU.
“The electro-microbial interface is the highest-velocity innovation zone: results from 2020–2022 converge on hybrid systems combining electrochemical CO₂ reduction with microbial bioconversion, with IP claims still early-stage and not yet consolidated by dominant assignees.”
Strategic Implications for R&D and IP Teams
The biocatalytic carbon capture landscape presents a set of distinct strategic signals for R&D leaders, IP counsel, and innovation portfolio managers. Five implications emerge directly from the dataset.
Akermin Inc.’s multi-year pilot data (2014) established technical feasibility for biocatalyst-enhanced potassium carbonate scrubbing of coal flue gas, achieving 80% CO₂ capture over 3,460 hours. No subsequent commercial-scale assignee is evident in the 2009–2024 dataset, representing a white space for IP positioning and scale-up investment.
Industrial enzyme delivery systems remain undercommercialized despite proven performance. Akermin’s pilot data established technical feasibility, yet no subsequent commercial-scale assignee is evident in this dataset. This represents a white space for IP positioning and scale-up investment, particularly as regulatory pressure on flue gas CO₂ intensifies under frameworks tracked by the EPA and equivalent national regulators.
The electro-microbial interface is the highest-velocity innovation zone. R&D teams should monitor C2 intermediate (acetate, ethanol) routing as the key design variable differentiating competing architectures. IP claims in this space are early-stage and not yet consolidated by dominant assignees in this dataset—creating a window for strategic filing.
China’s synthetic biology infrastructure is accelerating biocatalytic C1 chemistry. The concentration of Tianjin-based results in carboxylase mining and hybrid system design signals a coordinated national research program. Non-Chinese actors should assess freedom-to-operate carefully as this work matures toward patent filings, consistent with the IP landscape monitoring recommended by PatSnap’s innovation intelligence resources.
New-to-nature enzyme engineering will redefine the biocatalytic toolkit. The demonstrated three-orders-of-magnitude efficiency gain for GCC (CNRS, 2021) sets a precedent for rapid biocatalyst improvement. IP strategy should focus on protecting both specific enzyme sequences and the platform methodologies—particularly microfluidic screening workflows—that generate them.
Product-integrated carbon capture reduces overall system cost. Multiple results document systems where CO₂ capture and valorization occur in the same reactor. Techno-economic advantage accrues to architectures that eliminate the separate capture, compression, and transport steps inherent to CCS. Product-integrated biocatalytic systems—formate cycling, bioplastics, citric acid—should be prioritised in portfolio construction. For teams building out their biocatalytic CO₂ IP strategy, PatSnap Eureka’s patent landscape tools provide real-time claim mapping across all four technical clusters described in this report.
CNRS/Centre de Recherche Paul Pascal developed glycolyl-CoA carboxylase (GCC) using rational design combined with high-throughput microfluidics-assisted directed evolution, achieving a three-orders-of-magnitude improvement in catalytic efficiency for CO₂ fixation, verified by a 1.96 Å cryo-EM crystal structure, as reported in 2021.